ロード中...
Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation
BACKGROUND: While molecularly targeted therapies and immune checkpoint inhibitors have improved the prognosis of advanced melanoma, biomarkers are required to monitor drug responses. Circulating tumor cells (CTCs) are released from primary and/or metastatic tumors into the peripheral blood. We exami...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7968258/ https://ncbi.nlm.nih.gov/pubmed/33731038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08016-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|